PETER CORTA: Open Payments
NPI 1285687129 · STEPHENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 22 payments from 12 companies in 2025. Trend: 2023 $14 · 2024 $197 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Exact Sciences Corporation | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| ABBVIE INC. | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novo Nordisk Inc | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: JARDIANCE, REXULTI, Cologuard Collection Kit, CAPLYTA, VRAYLAR, TZIELD, KRYSTEXXA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
